For the readers interested in the stock health of Heat Biologics Inc. (HTBX). It is currently valued at $7.36. When the transactions were called off in the previous session, Stock hit the highs of $10.85, after setting-off with the price of $6.87. Company’s stock value dipped to $6.61 during the trading on the day. When the trading was stopped its value was $9.60.
Recently in News on June 4, 2021, Heat Biologics to Showcase Favorable Survival Data of HS-110 in Previously Treated Non-Small Cell Lung Cancer Patients at 2021 American Society of Clinical Oncology Annual Meeting. Survival benefit observed in two treatment settings of previously treated non-small lung cancer patients. You can read further details here
Heat Biologics Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $17.00 on 02/09/21, with the lowest value was $5.22 for the same time period, recorded on 01/04/21.
Heat Biologics Inc. (HTBX) full year performance was 66.09%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Heat Biologics Inc. shares are logging -75.55% during the 52-week period from high price, and 50.22% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $4.90 and $30.10.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 3256235 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Heat Biologics Inc. (HTBX) recorded performance in the market was 79.10%, having the revenues showcasing 4.35% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 247.30M, as it employees total of 39 workers.
Market experts do have their say about Heat Biologics Inc. (HTBX)
During the last month, 4 analysts gave the Heat Biologics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 7.56, with a change in the price was noted +0.58. In a similar fashion, Heat Biologics Inc. posted a movement of +8.40% for the period of last 100 days, recording 1,940,261 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for HTBX is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Technical breakdown of Heat Biologics Inc. (HTBX)
Raw Stochastic average of Heat Biologics Inc. in the period of last 50 days is set at 34.81%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 33.53%. In the last 20 days, the company’s Stochastic %K was 63.91% and its Stochastic %D was recorded 75.90%.
Bearing in mind the latest performance of Heat Biologics Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 79.10%. Additionally, trading for the stock in the period of the last six months notably improved by 24.68%, alongside a boost of 66.09% for the period of the last 12 months. The shares increased approximately by 46.12% in the 7-day charts and went down by 57.12% in the period of the last 30 days. Common stock shares were driven by 4.35% during last recorded quarter.